We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.85B
Cap. Flow %
-89.66%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.1 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.1 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Miscellaneous 10.26%
5 Real Estate 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LIN icon
551
Linde
LIN
$226B
– –
-6,800
Closed -$2.53M –
LYFT icon
552
Lyft
LYFT
$6.03B
– –
-10,000
Closed -$105K –
MELI icon
553
Mercado Libre
MELI
$97.4B
– –
-4,000
Closed -$5.07M –
MFA icon
554
MFA Financial
MFA
$683M
– –
-226,894
Closed -$2.18M –
MRK icon
555
Merck
MRK
$358B
– –
-5,790
Closed -$596K –
MTZ icon
556
MasTec
MTZ
$16.6B
– –
-26,295
Closed -$1.89M –
NAMS icon
557
NewAmsterdam Pharma
NAMS
$2.57B
– –
-45,000
Closed -$416K –
NKE icon
558
Nike
NKE
$52.1B
– –
-80,000
Closed -$7.65M –
NRDY icon
559
Nerdy
NRDY
$54.9M
– –
-3,333
Closed -$185K –
NTR icon
560
Nutrien
NTR
$32.3B
– –
-150,600
Closed -$9.3M –
NVCR icon
561
CALL
NovoCure
NVCR
$1.69B
– –
-25,000
Closed -$19.4K –
NVO icon
562
CALL
Novo Nordisk
NVO
$170B
– –
-20,000
Closed -$30K –
OMF icon
563
CALL
OneMain Financial
OMF
$6.45B
– –
-32,500
Closed -$14.6K –
ORIC icon
564
PUT
Oric Pharmaceuticals
ORIC
$1.23B
– –
-100,000
Closed -$285K –
PRQR icon
565
ProQR Therapeutics
PRQR
$222M
– –
-189,328
Closed -$246K –
QCOM icon
566
Qualcomm
QCOM
$186B
– –
-72,500
Closed -$8.05M –
REPL icon
567
CALL
Replimune Group
REPL
$1.27B
– –
-40,000
Closed -$115K –
RLAY icon
568
CALL
Relay Therapeutics
RLAY
$3.93B
– –
-80,000
Closed -$40K –
RNG icon
569
RingCentral
RNG
$6.47B
– –
-9,155
Closed -$271K –
ROKU icon
570
Roku
ROKU
$22.7B
– –
-43,972
Closed -$3.1M –
RYTM icon
571
CALL
Rhythm Pharmaceuticals
RYTM
$6.22B
– –
-45,000
Closed -$49.5K –
RYTM icon
572
Rhythm Pharmaceuticals
RYTM
$6.22B
– –
-30,000
Closed -$946K –
SLRN icon
573
CALL
DELISTED
ACELYRIN
SLRN
– –
-14,500
Closed -$4.71K –
SMH icon
574
PUT
VanEck Semiconductor ETF
SMH
$72.3B
– –
-105,000
Closed -$287K –
SNOW icon
575
Snowflake
SNOW
$127B
– –
-3,098
Closed -$473K –

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.85B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.